| HOME >> BIOLOGY >> TECHNOLOGY |
Jim Slevin Joins from CV Therapeutics as Senior Director of Account
Management, Integrated Healthcare Management
PARSIPPANY, N.J., Oct. 8 /PRNewswire/ -- Valeritas, LLC, a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced today that it has hired Jim Slevin to serve as the Senior Director of Account Management, Integrated Healthcare Management.
Mr. Slevin will join the Integrated Healthcare Management team reporting directly to Matt Nguyen, PharmD. Jim will be responsible for reimbursement strategies, marketing programs and contract development with national, regional, and government payers for Valeritas products in the metabolism arena. In the near term, he will focus on the h-Patch(TM) -- a once-daily, disposable insulin delivery device that is scheduled for a regional launch in Q1 2008.
"Jim comes to Valeritas with more than 20 years of experience in account management, during which he developed vast relationships and earned significant respect from his customers," said Robert Gonnelli, President and CEO of Valeritas. "Jim has been part of managed care since its infancy, has seen it grow and evolve, and knows the importance of success in this arena. His stellar track record in previous launches to ensure access and more importantly, preferred status, will no doubt contribute to the overall success of the h-Patch(TM) launch."
"Being part of the h-Patch(TM) launch is truly exciting," said Mr.
Slevin. "The burden of diabetes in the U.S. from a payor's perspective is
significant. The h-Patch(TM) is a first-in-class technology with a
significant opportunity to improve patient care. With its ease of use and
potential to improve patient compliance and control, h-Patch(TM)
utilization can help reduce overall healthcare costs for patients with
diabetes. I look forward to working with my customers to share the
cost-benefits associated with the h-Pat
'/>"/>
| SOURCE Valeritas, LLC Copyright©2007 PR Newswire. All rights reserved |